Rekombinanter HLA-A2 Antikörper
-
- Target
- HLA-A2
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
- Maus
- Expressionssystem
- Mammalian cells
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Recombinant Anti-HLA-A2-peptide (YLEPGPVT) Complex (2C5)
- Aufreinigung
- Protein A or G purified from cell culture supernatant.
- Reinheit
- >95 %
- Klon
- 2C5
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
- Target
- HLA-A2
- Hintergrund
- HLAA,Human leukocyte antigen A,HLA class I histocompatibility antigen,A alpha chain,HLA-A,ME20M,Melanocyte protein PMEL,Silver locus protein homolog,Secreted melanoma-associated ME20 antigen,D12S53E,95 kDa melanocyte-specific secreted glycoprotein,SILV,P100,Premelanosome protein,PMEL17,ME20S,PMEL,ME20-S,ME20-M,P26,P1,Melanocytes lineage-specific antigen GP100,Melanocyte protein Pmel 17,Melanoma-associated ME20 antigen
-